When: Confirmed reversal pattern (hammer/engulfing) at SMA with declining volume

Then: Deploy remaining 25% of intended add

When: Breakout above $356 with expanding volume and MACD bullish crossover

Then: Re-add trimmed position

HOLD - Do not add into bearish technical configuration; wait for 200 SMA test with confirmation candle or reclaim of 50 SMA with expanding volume and bullish MACD crossover

• Berkshire's 83% accumulation is a multi-year signal, not a tactical entry cue; Ackman trimmed 25% in the same quarter
• GOOGL fundamentals are exceptional (48.7% ROE, $242B cash, 34% operating margins) but stock trades below 10 EMA and 50 SMA with confirmed intermediate-term bearish configuration
• MACD re-crossed below signal on August 11 and has been expanding negative since — fresh deterioration, not stale signal
• ATR contraction resolves in both directions; failed bounce attempt with macro headwinds (rising yields, Iran oil spike) makes bullish resolution an assertion not probability
• Forward P/E of 23x looks stretched if 10-year yields push toward 5%; Polymarket pricing doesn't predict where yields go
• Q2 2026 free cash flow was negative minus $5.9 billion — stock down 8% from August 4 high of $377 as market sells rather than looks through it
• Proposed tactical Buy at $340 with $320 stop is essentially two ATRs (ATR=9.62) from entry, historically poor survival rate through normal market noise in a 1.24 beta stock
• Stock approximately 2.5% above 200-day moving average with next support at lower Bollinger band around $318; 200 SMA break would be severe technical damage
• Sentiment score of 6.7/10 with medium confidence reflects tepid, low-conviction reading where bullish retail discussion is absence of opposition not active affirmation
• Conservative plan targets $332 entry on confirmation with $317 stop below 200 SMA versus aggressive $340 entry with $320 stop above 200 SMA — $8 of insurance for better technical entry

→ vs aggressive: Berkshire's 83% accumulation is a long-term holding signal, not a tactical timing indicator; 13F reports past activity not future price targets; Ackman trimmed 25% in same quarter showing even value managers rotated out

→ vs aggressive: MACD is not a stale lagging indicator — it re-crossed below signal on August 11 and has been expanding negative since; fresh deterioration contradicts bullish framing

→ vs aggressive: Volatility contraction resolves bidirectionally; aggressive framing assumes bullish resolution without evidence; technical report itself concludes downside is higher probability

→ vs aggressive: Forward P/E of 23x is not priced for worst if yields move toward 5%; Treasury intervention has failed to contain long end; Iran escalation adds headwind

→ vs aggressive: Q2 2026 FCF was negative minus $5.9 billion; market is selling the stock not buying it; narrative hasn't shifted from secular AI play to cash burn machine yet

→ vs aggressive: 2.5-to-1 reward-to-risk ignores probability weighting; stock has bearish short-term and intermediate-term momentum, hostile macro, negative FCF, and sits near only major support level

→ vs aggressive: Sentiment of 6.7/10 is muddled low-conviction reading from thin sample; Reddit volume too low for strong community read; bullish discussion is absence of opposition not active affirmation

→ vs aggressive: Tactical Buy at $340 with $320 stop asks to add below both EMAs, below VWMA, into deteriorating momentum and worse macro; 6% buffer in 1.24 beta stock with 9.62 ATR is essentially coin-flip for surviving normal volatility expansion

HOLD at current weights with tiered add framework (25%/50%/25% on RSI oversold/200 SMA reclaim/confirmed reversal); trim 10-15% into $352-356 resistance; stop at $317

• Berkshire accumulated position over Q2 at lower prices — structural bid exists but not a green light to add today
• Aggressive analyst misquoted own technical report; 'higher-probability downside' conclusion was selectively edited
• Aggressive analyst's stop at $320 sits inside noise band (two ATRs from $340 entry vs. lower Bollinger at $318.31 and July capitulation low $317.69) — poor survival rate
• Conservative analyst overcorrects by treating accumulation as zero-information; three major managers adding same name is structural data even without date stamp
• Conservative analyst's wait-for-$332-reversal trigger misses fast V-shaped recoveries common in heavily-sponsored names; July 23 capitulation low $317.69 bounced without clean daily hammer
• Q2 FCF negative $5.9 billion driven by $44.9 billion capex and $11.7 billion working capital headwind — one-time effect, not structural deterioration
• 23x forward multiple on Alphabet looks expensive if 10-year pushes to 5% — aggressive analyst anchoring to current rates is a blind spot
• Sentiment score 6.7/10 described as 'absence of opposition rather than active affirmation' — reading as buy signal is motivated reasoning at intermediate-term top
• 200 SMA at $332 is structural line; daily close above it means long-term bull case technically intact
• Stop at $317 is non-negotiable — daily close below July capitulation low of $317.69 breaks structural bull thesis regardless of cost basis

→ vs aggressive: Stop placement at $320 is indefensible — two ATRs (9.62) from $340 entry sits inside volatility noise band, above lower Bollinger at $318.31 and July capitulation low $317.69, with historically terrible survival rates on normal volatility expansion

→ vs aggressive: Coiled spring thesis misrepresented — cited technical report explicitly states 'downside resolution is higher-probability outcome'; aggressive analyst quoted supporting language and omitted contrary conclusion

→ vs aggressive: Institutional flow argument misapplied as timing signal; Berkshire accumulated over Q2 at lower prices (already sitting on gains), not buying at $340; signal is 'bid exists on weakness' not 'chase now'

→ vs aggressive: Sentiment score read as confirmation bias — 6.7/10 with medium confidence and 'absence of opposition rather than active affirmation' is not a buy signal

→ vs conservative: Waiting for textbook reversal candle at 200 SMA sacrifices real alpha — July 23 capitulation low $317.69 bounced without clean daily hammer; clean confirmation often means $10-15 off the low

→ vs conservative: Treating cost of waiting as zero is wrong — 200 SMA frequently tested via sharp intraday wick without daily close below it in heavily-sponsored names

→ vs conservative: Negative Q2 FCF dismissed as 'distortion' by aggressive analyst but treated as structural problem by conservative analyst — both misread one-time $44.9B capex + $11.7B working capital headwind

→ vs conservative: Trim targets at $352-356 lack contingency — no plan for V-shaped recovery that reclaims $356 on expanding volume with MACD bullish crossover; plan treats trim zones as exits rather than rebalancing opportunities